1.
J Am Acad Dermatol
; 83(4): 1215-1218, 2020 Oct.
Article
in English
| MEDLINE
| ID: mdl-32622141
Subject(s)
Betacoronavirus/isolation & purification , Biological Products/adverse effects , Coronavirus Infections/epidemiology , Immunosuppressive Agents/adverse effects , Pneumonia, Viral/epidemiology , Skin Diseases/drug therapy , Adult , Aged , Aged, 80 and over , Betacoronavirus/immunology , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/immunology , Coronavirus Infections/transmission , Cross-Sectional Studies , Disease Susceptibility/immunology , Female , Hospitalization/statistics & numerical data , Humans , Immunocompromised Host , Male , Massachusetts/epidemiology , Middle Aged , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/immunology , Pneumonia, Viral/transmission , Retrospective Studies , SARS-CoV-2 , Skin Diseases/immunology , Time Factors
2.
Pediatr Dermatol
; 36(1): e44-e45, 2019 Jan.
Article
in English
| MEDLINE
| ID: mdl-30338558
ABSTRACT
Alopecia areata (AA) is relatively common and can have a significant impact on quality of life, especially in a pediatric population. Currently available treatments are often ineffective or have poor safety profiles. Recent studies have highlighted the importance of the Th1 pathway in the pathogenesis of AA, suggesting ustekinumab as a treatment modality for this disease. We present three pediatric AA patients who demonstrated hair regrowth after initiating ustekinumab.
Subject(s)
Alopecia Areata/drug therapy , Dermatologic Agents/therapeutic use , Ustekinumab/therapeutic use , Adolescent , Child , Female , Hair/drug effects , Hair/growth & development , Humans
3.
J Am Acad Dermatol
; 80(5): 1451-1453, 2019 May.
Article
in English
| MEDLINE
| ID: mdl-30395914
Subject(s)
Boron Compounds/adverse effects , Bridged Bicyclo Compounds, Heterocyclic/adverse effects , Dermatitis, Atopic/drug therapy , Pain/chemically induced , Phosphodiesterase 4 Inhibitors/adverse effects , Administration, Cutaneous , Adolescent , Adult , Boron Compounds/administration & dosage , Bridged Bicyclo Compounds, Heterocyclic/administration & dosage , Child , Face , Female , Humans , Male , Middle Aged , Phosphodiesterase 4 Inhibitors/administration & dosage , Retrospective Studies , Young Adult
4.
J Am Acad Dermatol
; 81(1): 265-267, 2019 07.
Article
in English
| MEDLINE
| ID: mdl-30562567
Subject(s)
Antibodies, Monoclonal/therapeutic use , Drug Approval , Hidradenitis Suppurativa/diagnosis , Hidradenitis Suppurativa/drug therapy , Adult , Aged , Antibodies, Monoclonal, Humanized , Cohort Studies , Female , Follow-Up Studies , Humans , Injections, Subcutaneous , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Treatment Outcome , United States , United States Food and Drug Administration , Young Adult
5.
JAMA Dermatol
; 154(10): 1225-1226, 2018 10 01.
Article
in English
| MEDLINE
| ID: mdl-30140849
